Rapamycin causes poorly reversible inhibition of mTOR and induces p53- independent apoptosis in human rhabdomyosarcoma cells

Pharmacology, Toxicology and Pharmaceutical Science

• Mammalian Target of Rapamycin 100%
• Apoptosis 90%
• Protein P53 30%
• Somatomedin C 30%
• Rhabdomyosarcoma 30%
• Protein 20%
• Tacrolimus 20%
• Cell Cycle 20%
• Biological Product 10%
• Anticarcinogen 10%
• S6 Kinase 10%
• Growth Disorder 10%
• Cytosol Receptor 10%
• Absence 10%
• Clinical Trial 10%
• Survival 10%
• Cell Culture 10%
• Growth Factor 10%

Neuroscience

• Mammalian Target of Rapamycin 100%
• Apoptosis 90%
• Cell Line 30%
• P53 30%
• Insulin-Like Growth Factor 1 30%
• Protein 20%
• FKBP 20%
• Cell Growth 10%
• Cell Cycle Progression 10%
• Growth Factor 10%
• Cell Survival 10%
• Cell Culture 10%
• Cell Cycle G1 Phase 10%
• G1 Phase Cell Cycle Checkpoint 10%
• S6 Kinase 10%
• Cytosol Receptor 10%